The newer antimuscarinic drugs: Bladder control with less dry mouth

被引：19

作者：

Appell, RA ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Urol, Houston, TX 77030 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2002年 / 69卷 / 10期

关键词：

D O I：

10.3949/ccjm.69.10.761

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Two newer antimuscarinic anticholinergic drugs-tolterodine and extended-release oxybutynin-are approximately as effective in treating overactive bladder as immediate-release oxybutynin, but are more tolerable. I review clinical trial data on the newer agents.

引用

页码：761 / +

页数：5

共 19 条

[1]

Abrams P, 1998, BRIT J UROL, V81, P801

[2]

Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence [J].